without comments
Pre-phase II R&D accounts for about 35% of total R&D spending:
Source: PhRMA, 2009
Written by admin
February 12th, 2010 at 10:17 am
Posted in Chart of the Day, Clinical trial analysis
Tagged with clinical trials, pharmaceuticals, phase I, phase II, phase III, phase IV, research and development
Name (required)
Mail (will not be published) (required)
Website
www.trialdox.com
